Fund Holdings — Frazier Life Sciences Management, L.P.

Total Portfolio Value:
$2.19B
Total Bought:
$309.29M
Total Sold:
$251.23M
Net Transaction:
+$58.06M
Notable People:
James Newman Topper, Patrick James Heron, Daniel Estes, James Brush, Albert (Nmn) Cha, Frazier Life Sciences Management,
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Newamsterdam Pharma Company
ORDINARY SHARES
15,916,41816,116,418+200,000$409.05M$329.90M15.08%-$79.15M
Mirum Pharmaceuticals, Inc.(MIRM)6,570,3926,795,121+224,729$271.69M$306.12M13.99%+$34.43M
Verona Pharma PlcADS3,383,9503,457,850+73,900$157.15M$219.54M10.03%+$62.39M
Arcutis Biotherapeutics, Inc.(ARQT)8,785,2848,785,2840$122.38M$137.40M6.28%+$15.02M
BridgeBio Pharma, Inc.(BBIO)3,800,4573,800,4570$104.28M$131.38M6.00%+$27.10M
Krystal Biotech, Inc.(KRYS)788,460688,460-100,000$123.52M$124.13M5.67%+$609.2K
Disc Medicine, Inc.(IRON)1,754,8341,754,8340$111.26M$87.11M3.98%-$24.15M
Tarsus Pharmaceuticals, Inc.(TARS)1,587,5271,397,527-190,000$87.90M$71.79M3.28%-$16.11M
Trevi Therapeutics, Inc.(TRVI)10,664,77410,259,409-405,365$43.94M$64.53M2.95%+$20.59M
Phathom Pharmaceuticals, Inc.(PHAT)10,109,27910,109,2790$82.09M$63.39M2.90%-$18.70M
Kalvista Pharmaceuticals Inc4,887,8674,887,8670$41.40M$56.41M2.58%+$15.01M
Maze Therapeutics, Inc.(MAZE)04,129,001+4,129,001$0$45.46M2.08%+$45.46M
MBX Biosciences, Inc.(MBX)5,985,3475,985,3470$110.31M$44.17M2.02%-$66.14M
Rhythm Pharmaceuticals, Inc.(RYTM)1,869,808678,760-1,191,048$104.67M$35.95M1.64%-$68.72M
Soleno Therapeutics Inc699,159499,159-200,000$31.43M$35.66M1.63%+$4.24M
Revolution Medicines, Inc.(RVMD)997,455997,4550$43.63M$35.27M1.61%-$8.36M
Savara Inc.(SVRA)8,660,37911,462,301+2,801,922$26.59M$31.75M1.45%+$5.16M
Agios Pharmaceuticals, Inc.(AGIO)1,069,7541,069,854+100$35.15M$31.35M1.43%-$3.81M
Erasca, Inc.(ERAS)19,391,68722,575,851+3,184,164$48.67M$30.93M1.41%-$17.74M
Ultragenyx Pharmaceutical Inc.(RARE)658,715658,7150$27.71M$23.85M1.09%-$3.86M
Ascendis Pharma A/SADR(ASND)133,333133,3330$18.36M$20.78M0.95%+$2.43M
Vaxcyte, Inc.(PCVX)539,405539,4050$44.16M$20.37M0.93%-$23.79M
Alkermes plcSHS(ALKS)601,129601,1290$17.29M$19.85M0.91%+$2.56M
Palvella Therapeutics, Inc.(PVLA)653,892690,012+36,120$7.85M$19.31M0.88%+$11.47M
CG Oncology, Inc.(CGON)770,000770,0000$22.08M$18.86M0.86%-$3.23M
Mereo BioPharma Group plcADS(MREO)5,097,7797,819,863+2,722,084$17.84M$17.59M0.80%-$247.5K
Merus N V373,100373,1000$15.69M$15.70M0.72%+$14.9K
Avidity Biosciences Inc0525,000+525,000$0$15.50M0.71%+$15.50M
Hillevax Inc10,617,06210,617,0620$21.98M$15.39M0.70%-$6.58M
Dyne Therapeutics, Inc.(DYN)01,443,341+1,443,341$0$15.10M0.69%+$15.10M
Zai Lab LimitedADR(ZLAB)0350,000+350,000$0$12.65M0.58%+$12.65M
Immunocore Holdings plcADS(IMCR)108,762301,170+192,408$3.21M$8.94M0.41%+$5.73M
ORIC Pharmaceuticals, Inc.(ORIC)3,888,2381,410,193-2,478,045$31.38M$7.87M0.36%-$23.51M
Acadia Pharmaceuticals Inc470,338470,3380$8.63M$7.81M0.36%-$818.4K
Design Therapeutics, Inc.(DSGN)1,953,5471,953,5470$12.05M$7.54M0.34%-$4.51M
Rocket Pharmaceuticals, Inc.(RCKT)1,479,0251,079,025-400,000$18.59M$7.20M0.33%-$11.39M
Autolus Therapeutics plcADS(AUTL)4,623,3244,623,3240$10.86M$7.17M0.33%-$3.70M
Oruka Therapeutics, Inc.(ORKA)583,327583,3270$11.31M$5.98M0.27%-$5.33M
Allogene Therapeutics Inc2,867,7503,868,750+1,001,000$6.11M$5.65M0.26%-$459.9K
Immatics N.V.SHS(IMTX)2,147,9111,247,911-900,000$15.27M$5.63M0.26%-$9.64M
Cogent Biosciences, Inc.(COGT)936,576936,5760$7.31M$5.61M0.26%-$1.70M
Adverum Biotechnologies Inc1,069,2441,069,2440$4.99M$4.67M0.21%-$320.8K
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
500,333500,3330$7.13M$4.50M0.21%-$2.63M
MacroGenics, Inc.(MGNX)3,175,6653,175,6650$10.32M$4.03M0.18%-$6.29M
Lexeo Therapeutics, Inc.(LXEO)955,515955,5150$6.29M$3.32M0.15%-$2.97M
Silence Therapeutics plcADS(SLN)1,148,5911,148,5910$7.90M$3.24M0.15%-$4.66M
Elevation Oncology Inc5,993,5795,993,5790$3.37M$1.55M0.07%-$1.82M
89bio Inc1,000,0000-1,000,000$7.82M$0—-$7.82M
Anaptysbio Inc1,573,7190-1,573,719$20.84M$0—-$20.84M
Arvinas, Inc.(ARVN)285,3310-285,331$5.47M$0—-$5.47M
Day One Biopharmaceuticals I
COM
689,6550-689,655$8.74M$0—-$8.74M
Edgewise Therapeutics, Inc.(EWTX)1,271,2450-1,271,245$33.94M$0—-$33.94M
Eledon Pharmaceuticals, Inc.(ELDN)1,176,7350-1,176,735$4.85M$0—-$4.85M
Pliant Therapeutics, Inc.(PLRX)1,120,8030-1,120,803$14.76M$0—-$14.76M
Page 1 of 1
Frazier Life Sciences Management, L.P. — 13F Holdings — Q1 2025 | TickerTrail